Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs

Sester U., Wilkens H., van Bentum K., Singh M., Sybrecht G. W., Schafers H-J., Sester M.

Source: Eur Respir J 2009; 34: 702
Journal Issue: September
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sester U., Wilkens H., van Bentum K., Singh M., Sybrecht G. W., Schafers H-J., Sester M.. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34: 702

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008

Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010



Intracellular ESAT-6 vs flow cytometric analysis of CD4+IFN-γ+ cells for the diagnosis of mycobacterium tuberculosis infection in immunosuppressed patients
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006



Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013

Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005


Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007



Mycolic acid from mycobacterium tuberculosis suppresses experimental asthma by triggering the local induction of regulatory T cells
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012



Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Paradoxical reactions (PR) related to tuberculosis (TB) treatment are associated with increased antigen-specific T cell responses in the lung
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Peripheral blood leukocyte subsets as markers of early TB treatment response
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011